• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PNV 1.94% $2.02

POLYNOVO LIMITED - Charts / Financials

PolyNovo Limited is an Australia-based medical device company, which is focused on... PolyNovo Limited is an Australia-based medical device company, which is focused on advanced wound care that designs, develops, and manufactures dermal regeneration solutions using its patented NovoSorb biodegradable polymer technology. Its solutions include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb MTX. NovoSorb BTM is a synthetic, biodegradable and biocompatible device designed to facilitate the dermis to grow within a patented polyurethane matrix when lost through extensive surgery, trauma or burn. NovoSorb BTM is indicated for use in the management of wounds, including partial and full thickness wounds, pressure ulcers, venous and diabetic ulcers, chronic and vascular ulcers, surgical wounds, trauma wounds and draining wounds. Its development program covers breast sling, hernia, and orthopedic applications. NovoSorb MTX is available in a range of sizes to address acute and chronic dermal wounds and is comprised of a 2mm biodegradable foam with no sealing membrane.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

refresh Created with Sketch. REFRESH
Last update - 15.59pm 01/11/2024 (20 minute delay) ?
Day
Open $2.01   Day High $2.04   Day Low $2.00
Daily Volume 762931
Bids   Sellers
Number Price Volume   Number Price Volume
1 $2.01 41008   2 $2.03 5942

Directors & Senior Management

Mr. Swami Raote Chief Executive Officer
Mr. Jan Gielen Chief Financial Officer
Mr. Ed Graubart President - North America
Mr. David Morris President - Asia Pacific
Ms. Ingrid Anderson Chief People Officer
Dr. David McQuillan Chief Technical and Scientific Officer
Mr. Philip Scorgie Chief Information Officer
Dr. Aurore Mulkens Vice President - Quality Affairs
Mr. Lior Harel General Counsel, Company Secretary
Mr. Joseph Amaral Chief Medical Officer
Mr. David John Williams Non-Executive Independent Chairman of the Board
Dr. Robyn Elliott Non-Executive Director
Ms. Christine Emmanuel-Donnelly Non-Executive Director
Mr. Leon Hoare Non-Executive Director
Mr. Andrew Stuart Lumsden Non-Executive Director

Data source: Refinitiv

(20min delay)
Last
$2.02
Change
-0.040(1.94%)
Mkt cap ! $1.395B
Open High Low Value Volume
$2.01 $2.04 $2.00 $1.537M 762.9K

Buyers (Bids)

No. Vol. Price($)
1 41008 $2.01
 

Sellers (Offers)

Price($) Vol. No.
$2.03 5942 2
View Market Depth
Last trade - 16.10pm 01/11/2024 (20 minute delay) ?
Last
$2.01
  Change
-0.040 ( 1.96 %)
Open High Low Volume
$2.01 $2.04 $2.00 431774
Last updated 15.59pm 01/11/2024 ?
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.